🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Exploring the Genetics of Neuropathic Pain

Recruitingn/aAges 18 Years - 70 YearsAllOslo University Hospital
NCT03862365 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In the present study the investigators will search for new genetic variants relevant for the development of neuropathic pain.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. The patient is between 18 and 70 years old. 2. The patient has consented. 3. The patient is referred for evaluation of possible distal symmetric polyneuropathy (DSPN). 4. The patient has filled out the questionnaires. Exclusion Criteria: 1. The patient is too sick to participate (eg. bedridden, fever). 2. The patient is unable to consent (eg. dementia, speech problems, psychiatric disorder). 3. Inflammatory acute polyneuropathy.
💊

What it tests

  • Nerve conduction Studies
📍

Where

5 sites
Haukeland University Hospital
Bergen, Norway
Oslo University Hospital
Oslo, Norway
Helse Stavanger HF
Stavanger, Norway
University Hospital of North Norway
Tromsø, Norway
St. Olavs Hospital
Trondheim, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy